LENSAR, INC. Shareholders' Equity
LENSAR, INC. (LNSR) had Shareholders' Equity of $14.90 million as of 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Balance Sheet › Equity › Equity, Attributable to Parent
us-gaap:StockholdersEquity · last filed 2026-08-13
- 2026-06-30: Stockholders' Equity Attributable to Parent $14.90M.
- 2026-03-31: Stockholders' Equity Attributable to Parent $10.79M.
- 2025-12-31: Stockholders' Equity Attributable to Parent -$26.02M.
- 2025-09-30: Stockholders' Equity Attributable to Parent -$25.91M.
| Period end | Stockholders' Equity Attributable to Parent |
|---|---|
| 2026-06-30 | $14.90M 10-Q · filed 2026-08-13 |
| 2026-03-31 | $10.79M 10-Q · filed 2026-08-13 |
| 2025-12-31 | -$26.02M 10-Q · filed 2026-08-13 |
| 2025-09-30 | -$25.91M 10-Q · filed 2025-11-06 |
| 2025-06-30 | -$23.05M 10-Q · filed 2026-08-13 |
| 2025-03-31 | -$22.14M 10-Q · filed 2026-08-13 |
| 2024-12-31 | $4.86M 10-Q · filed 2026-08-13 |
| 2024-09-30 | $22.74M 10-Q · filed 2025-11-06 |
| 2024-06-30 | $23.64M 10-Q · filed 2025-11-06 |
| 2024-03-31 | $31.84M 10-Q · filed 2025-11-06 |
| 2023-12-31 | $33.43M 10-K · filed 2026-03-31 |
| 2023-09-30 | $36.38M 10-Q · filed 2024-11-07 |
| 2023-06-30 | $32.69M 10-Q · filed 2024-11-07 |
| 2023-03-31 | $39.44M 10-Q · filed 2024-11-07 |
| 2022-12-31 | $41.98M 10-K · filed 2025-02-27 |
| 2022-09-30 | $42.58M 10-Q · filed 2023-11-09 |
| 2022-06-30 | $44.90M 10-Q · filed 2023-11-09 |
| 2022-03-31 | $49.81M 10-Q · filed 2023-11-09 |
| 2021-12-31 | $54.88M 10-K · filed 2024-03-04 |
| 2021-09-30 | $57.05M 10-Q · filed 2022-11-09 |
| 2021-06-30 | $61.63M 10-Q · filed 2022-11-09 |
| 2021-03-31 | $64.33M 10-Q · filed 2022-11-09 |
| 2020-12-31 | $67.21M 10-K · filed 2023-03-16 |
| 2020-09-30 | $68.95M 10-Q · filed 2021-11-08 |
| 2020-06-30 | -$36.27M 10-Q · filed 2021-11-08 |
| 2020-03-31 | -$32.07M 10-Q · filed 2021-11-08 |
| 2019-12-31 | -$30.55M 10-K · filed 2022-03-03 |
| 2019-09-30 | -$29.41M 10-Q · filed 2020-11-12 |
| 2019-06-30 | -$24.44M 10-Q · filed 2020-11-12 |
| 2019-03-31 | -$21.67M 10-Q · filed 2020-11-12 |
| 2018-12-31 | -$20.46M 10-K · filed 2021-03-12 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| SkinHealth Systems Inc. (SKIN) | United States | $0.086B | -3.17 |
| Microbot Medical Inc. (MBOT) | $0.089B | -7.97 | |
| Pulmonx Corp (LUNG) | United States | $0.082B | -1.16 |
| RenovoRx, Inc. (RNXT) | United States | $0.076B | -3.62 |
| FRACTYL HEALTH, INC. (GUTS) | United States | $0.075B | -1.18 |
| CVRx, Inc. (CVRX) | United States | $0.067B | -2.62 |
| DarioHealth Corp. (DRIO) | $0.066B | -1.39 | |
| TELA Bio, Inc. (TELA) | United States | $0.057B | -0.82 |
| Apyx Medical Corp (APYX) | United States | $0.120B | -21.85 |
| Xtant Medical Holdings, Inc. (XTNT) | United States | $0.053B |